Clinical Trials Logo

Communicable Diseases clinical trials

View clinical trials related to Communicable Diseases.

Filter by:

NCT ID: NCT05283239 Recruiting - HPV Infection Clinical Trials

Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection

Start date: January 1, 2022
Phase:
Study type: Observational

Clinically, patients with persistent HR-HPV infection for more than 18 months or HR-HPV infection with CIN2 + need regular colposcopic biopsy to assess the outcome and progression of the disease. A total of 1000 participants with persistent HR-HPV infection (100 cases/center) were recruited from multiple centers, and HPV integration status and vaginal flora diversity were sequenced at baseline, 6th month, 12th month and 24th month, respectively, through prospective cohort studies. And to evaluate the influence of HPV integration status and flora changes on the prognosis of women with persistent HR-HPV infection.

NCT ID: NCT05282485 Recruiting - HIV Clinical Trials

Mitigating Infectious Morbidity and Growth Deficits in HIV Exposed Uninfected infanTs With Human Milk Oligosaccharides

MIGH-T MO
Start date: June 2, 2022
Phase: N/A
Study type: Interventional

Primary Objective: - To evaluate the effects of synbiotics on infectious morbidity and growth while it is in place from 4 to 24 weeks of age. - To evaluate the effects of synbiotics on infectious morbidity and growth from 4 to 48 weeks of age. Secondary Objectives: - To evaluate the effects of synbiotics on growth from 4 to 72 weeks of age. - To evaluate the effects of synbiotics on infant neurodevelopment at 48 and 72 weeks of age. - To evaluate the effects of synbiotics on biological measurements while it is in place from 4 to 24 weeks of age. - To evaluate the effects of synbiotics on biological measurements from 4 to 48 weeks of age. - To evaluate the effects of synbiotics on gut microbiome and fecal short chain fatty acids from 4 to 72 weeks of age. - To investigate feasibility, acceptance, tolerability, and behavioral adherence with the intervention. - To investigate whether the synbiotics reduces infectious morbidity and improves growth in CHEU relative to CHUU. - To investigate whether infant gut microbiota composition, maturity and function, and markers of inflammation and HMOs at baseline and over time are associated with morbidity and poor growth in CHEU and CHUU.

NCT ID: NCT05275335 Recruiting - Burns Clinical Trials

Understanding the Burn Wound Microbiome: Comparing Traditional Wound Cultures to Next Generation Sequencing Technology

Start date: November 1, 2022
Phase:
Study type: Observational [Patient Registry]

The purpose of this investigation is to better understand the wound microbiome in burn wounds and the role it plays in outcomes and complications related to treatment.

NCT ID: NCT05266898 Recruiting - Clinical trials for Human Immunodeficiency Virus

Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV

AGO-Gard
Start date: November 30, 2022
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to determine the magnitude and breadth of the serum antibody response to the nonavalent HPV vaccine (Gardasil-9) in adults with well-controlled HIV infection. The secondary objective of the study is to observe short term clinical outcomes of prevalent HPV genotype-specific anogenital infections in adults living with HIV who complete the three-dose Gardasil-9 vaccine series. The clinical hypothesis is that adults with virologically controlled HIV mount a serum antibody response to the nonavalent HPV vaccine that is comparable to HIV negative counterparts. We also postulate that HPV vaccination will provide short-term clinical benefit against HPV infections and disease associated with vaccine genotypes.

NCT ID: NCT05266807 Recruiting - Clinical trials for Clostridioides Difficile Infection

Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence

FENDER
Start date: August 16, 2022
Phase: Phase 3
Study type: Interventional

The clinical trial aims to evaluate the efficacy of fecal microbiota transplantation (FMT) after standard of care treatment (either vancomycin or fidaxomicin) vs the pragmatic use of standard of care treatment (either vancomycin or fidaxomicin) in severe and non-severe first episode and first recurrence of Clostridioides difficile infection (CDI). Experimental arm: antibiotic treatment (vancomycin or fidaxomicin as initially prescribed per SoC continued for 10 days) followed by FMT by oral capsules (one FMT, i.e. 20 FMT capsules given on 2 consecutive days, and followed by a 2nd FMT in severe CDI). Control Arm: vancomycin or fidaxomicin as initially prescribed per SoC continued for 10 days.

NCT ID: NCT05264402 Recruiting - Clinical trials for Catheter-related Bloodstream Infection

Comparison of Early Phase Infections Risk Between Midline and Piccline Caheters: MIDLINE AND PICCLINE CATHETERS

PICCORMID
Start date: November 15, 2021
Phase:
Study type: Observational

A long-term venous access is frequently required in patient management. Currently, it is ensured by using the long peripheral intravenous catheters (Midline) or peripheral inserted central catheters (PICC line). Either is inserted into a peripheral vein of the upper arm and extends to the distal axillary vein. If the indications for the two catheters can sometimes be debated, the Midline catheter seems to be more and more used. The complications related to the use of PICC lines have been well described in literature, whereas the comparison of the two catheter-related complications has been less analysed. The aim of this study is to compare the incidences of catheter-related bloodstream infections linked to PICCs and Midlines.

NCT ID: NCT05259761 Recruiting - HIV Infections Clinical Trials

Overcoming Geography With Technology: Medical Drones Project

Start date: September 22, 2021
Phase:
Study type: Observational

In this study, the investigators shall evaluate the use unmanned air vehicles (medical drones) to deliver ART to adult patients eligible/enrolled in community DSD models in Bufumira Islands, Kalangala district. The geography of the islands is ideal for this project because of the flat landscape and water coverage. The investigators hypothesize that the use of drones would be acceptable to patients and stakeholders, reduce facility drug stock outs, increase retention in care by 10% in intervention (at 12 months) compared to the control health centres and be cost neutral (to the patients and health sector perspectives). The investigators will also undertake evaluation of an efficient sample delivery system using medical drones especially for expansive rural areas like Moyo and Adjumani.

NCT ID: NCT05254990 Recruiting - Severe COVID-19 Clinical Trials

Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

Start date: April 6, 2022
Phase: Phase 3
Study type: Interventional

Primary objective: - To evaluate the efficacy of oral reparixin versus standard care alone in limiting disease progression in adult patients hospitalised for infectious pneumonia acquired in the community (CAP), including COVID-19. Secondary objectives: - To determine the effect of reparixin on several disease severity/progression measures including recovery, ventilatory free days and mortality. Safety objectives: - To evaluate the safety of oral reparixin versus placebo in the specific clinical setting.

NCT ID: NCT05254522 Recruiting - Clinical trials for Fever of Unknown Origin

Fever of Unknown Orgin Registry in Internal Medicine Unit and Infectious Disease Units

FUO
Start date: September 19, 2019
Phase:
Study type: Observational [Patient Registry]

This registry has the aim to collect epidemiological and clinical data of classical FUO cases in Italian Internal medicine Dept. and in Italian Infection diseases Dept.

NCT ID: NCT05251584 Recruiting - Clinical trials for Peritoneal Dialysis-related Infection

Effects of Topical Gentamicin on the Prevention of Peritoneal Dialysis Related Infection

Start date: December 1, 2021
Phase: N/A
Study type: Interventional

Peritoneal dialysis-related infection is a complication that leads to peritoneal dialysis catheter removal or patient death. The present study aimed to investigate peritoneal dialysis-related infection, causative pathogens resulting in topical 2% mupirocin ointments period compare with 0.1% gentamicin cream period. Rate of catheter removal, time to first peritoneal dialysis-related infection after apply gentamicin cream.